Immerz Inc. – Trademark Portfolio

Entity Type: 03

Immerz Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include IMMERZ and KOR-FX. The owner is based in Cambridge, MA.

One Broadway, 14th Floor

Cambridge, MA 02142

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KOR-FX
KOR-FX
Registered 2009
IMMERZ
IMMERZ
Registered 2009
KOR-FX
KOR-FX
Abandoned 2009

Trademark Classifications

Immerz Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (4 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Immerz Inc. have?

Immerz Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 abandoned.

What trademark classes does Immerz Inc. file in?

Immerz Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Immerz Inc.'s most well-known trademarks?

Immerz Inc.'s registered trademark portfolio includes well-known marks such as IMMERZ and KOR-FX. These are among 2 currently registered trademarks in the portfolio.

What is Immerz Inc.'s trademark registration success rate?

Immerz Inc. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.